Submission Details
| 510(k) Number | K173330 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | October 23, 2017 |
| Decision Date | June 01, 2018 |
| Days to Decision | 221 days |
| Submission Type | Traditional |
| Review Panel | Microbiology (MI) |
| Summary | Summary PDF |
K173330 is an FDA 510(k) clearance for the PanNAT STEC Test, a Gastrointestinal Bacterial Panel Multiplex Nucleic Acid-based Assay System (Class II — Special Controls, product code PCI), submitted by Micronics, Inc. (Redmond, US). The FDA issued a Cleared decision on June 1, 2018, 221 days after receiving the submission on October 23, 2017. This device falls under the Microbiology review panel. Regulated under 21 CFR 866.3990.
| 510(k) Number | K173330 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | October 23, 2017 |
| Decision Date | June 01, 2018 |
| Days to Decision | 221 days |
| Submission Type | Traditional |
| Review Panel | Microbiology (MI) |
| Summary | Summary PDF |
| Product Code | PCI — Gastrointestinal Bacterial Panel Multiplex Nucleic Acid-based Assay System |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 866.3990 |
| Definition | A Gastrointestinal Bacterial Panel Multiplex Nucleic Acid Assay Is A Qualitative In Vitro Diagnostic Device Intended To Simultaneously Detect And Identify Multiple Gastrointestinal Bacterial Nucleic Acids Extracted From Human Stool Specimens. The Detection And Identification Of A Specific Gastrointestinal Bacterial Nucleic Acid From Individuals Exhibiting Signs And/or Symptoms Of Gastrointestinal Infection Aids In The Diagnosis Of Gastrointestinal Infection When Used In Conjunction With Clinical Evaluation And Other Laboratory Findings. |